Evoke Pharma, Inc. (NASDAQ:EVOK) Q4 2024 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Evoke Pharma, Inc. Fourth Quarter and Full Year 2024 Earnings Conference Call. Currently, all callers have been placed in a listen-only mode.
Evoke Pharma, Inc. (EVOK) Q4 2024 Earnings Call Transcript
Evoke Pharma, Inc. ( NASDAQ: EVOK) Q4 2024 Earnings Conference Call March 13, 2025 4:30 PM ET Daniel Kontoh-Boateng – DKB Partners Matt D’Onofrio – Chief Executive Officer Chris Quesenberry – Chief ...
The Manila Times6d
Evoke Pharma, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
SOLANA BEACH, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical ...
BMJ1mon
Methotrimeprazine versus haloperidol in palliative care patients with cancer-related nausea: a randomised, double-blind controlled trial
The most recent guidelines recommend metoclopramide as first-line treatment, with haloperidol, levomepromazine or olanzapine as alternative options.4 The evidence to support the use of other ...